Co-Diagnostics receives Australian patent covering Co-Dx PCR platform technologies for nucleic acid detection and analysis: Salt Lake City Wednesday, December 31, 2025, 11:00 Hrs ...
Inc. (Nasdaq: CODX) ("Co-Dx" or "the Company"), a molecular diagnostics company with a unique, patented platform for the ...
The Australian patent represents the first patent granted for the Company's new point-of-care testing platformSALT LAKE CITY, ...
This study offers important insight into the pathogenic basis of intragenic frameshift deletions in the carboxy-terminal domain of MECP2, which account for some Rett syndrome cases, yet similar ...
The catalogue, which lists the sectors carrying policy incentives for overseas investors, has hundreds of new entries, many ...
Mumbai: For weeks, a shortage of cartridges for rapid tuberculosis tests has hampered the city's ability to diagnose ...
Korea's first fully automated diagnostic system capable of simultaneously detecting 16 major foodborne pathogens within one ...
A research team led by Senior Researcher Chanyong Park, Principal Researcher Dongkyu Lee, and Postdoctoral Researcher Changha ...
Applied BioCode, a leader in innovative molecular diagnostic solutions, announced today the submission of a new nucleic acid ...
Applied BioCode, a leader in innovative molecular diagnostic solutions, announced today the submission of a new nucleic acid extraction claim for the KingFishertm Flex Nucleic Acid Purification System ...
Surat: Surat Raktdan Kendra and Research Centre (SRKRC) has upgraded its Nucleic Acid Testing (NAT) system, further strengthening the safety of blood .
Abstract: Nucleic Acid Amplification Tests (NAATs) are used to diagnose infectious diseases such as tuberculosis (TB), SARS-CoV-2, and Human Papillomavirus (HPV). Conventional testing requires a bench ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results